Dr. Santini is an Assistant Professor of Medicine at Icahn School of Medicine at Mount Sinai. Her research interest focuses on regenerative medicine, with the specific goal of understanding the mechanisms regulating fibro-adipogenic response in multiorgan studies. Dr. Santini was trained as a molecular and cellular biologist, she received her PhD in molecular biology from Heidelberg University and the European Biology Laboratory, Heidelberg, Germany, and completed her postdoctoral training in regenerative medicine at Imperial College London, London, UK. Her research uses transgenic technologies as well as in vivo and ex vivo cardiac and kidney disease models to investigate cell signaling, tissue cross-talk, revascularization, and regeneration. Methodological analyses of murine and human samples are performed using cell lineage microsopy analyses and multi-platform omics technologies to identify key drivers of cardiac and renal diseases. Important targets for complex disease analyses include the Insulin-like Growth Factor-1 as a therapeutic and pharmacological agent, Notch downstream molecules and Platelet-Derived Growth Factor Receptor alpha as specific modulators of heart and kidney failure. She enjoys traveling and meeting people from different cultures. Her motto is ‘Travel makes one modest. You see what a tiny place you occupy in the world, Gustave Flaubert’